You just read:

Statement from FDA Commissioner Scott Gottlieb, M.D. on the FDA's new policy steps and enforcement efforts to ensure proper oversight of stem cell therapies and regenerative medicine

News provided by

U.S. Food and Drug Administration

Aug 28, 2017, 09:24 ET